|
|
Immunoglobulins, Intravenous
Research News and Information
Definition of 'Immunoglobulins, Intravenous'Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. |
Sunday, November 22, 2009
13 Dec 2009
EBV-associated post-transplant lymphoproliferative disorder (PTLD) is a well-recognized complication following solid organ transplantation and hematopoietic stem cell transplantation (HSCT) using bone marrow or peripheral blood as stem cell sources, ... Read more...
Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009.
4 Nov 2009
Since 2003, the U.S. Department of Agriculture's Wildlife Services has coordinated a multistate oral rabies vaccination (ORV) program for wildlife in a 15-state zone extending from Maine to Alabama and in Texas. The program seeks to enhance local ... Read more...
29 Sep 2009
Intravenous immunoglobulin (IVIg) is used for treatment of a variety of immunological disorders and in transplantation. As one of its applications in transplantation is the reduction of donor specific antibodies in the circulation, we examined the ... Read more...
Latest indexed articles for 'Immunoglobulins, Intravenous'
These are the very latest articles for this heading:
- Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
13 Dec 2009 - Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009.
4 Nov 2009 - Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.
18 Oct 2009 - Single immunoglobulin infusion can reverse hemodynamic failure associated with severe Clostridium difficile colitis.
29 Sep 2009 - Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production.
29 Sep 2009 - Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
27 Sep 2009 - A pilot study of equal doses of 10% IGIV given intravenously or subcutaneously.
17 Sep 2009 - Microthrombocytopenia in a male infant with cytomegalovirus.
30 Aug 2009 - 11q terminal deletion disorder and common variable immunodeficiency.
30 Aug 2009 - A close look at human IgG sialylation and subclass distribution after lectin fractionation.
30 Aug 2009 - Progress in pediatric vasculitis.
30 Aug 2009 - A 3-day-old boy with acute flaccid paralysis.
30 Aug 2009 - Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
30 Aug 2009 - Towards evidence based medicine for paediatricians. Is intravenous immunoglobulin superior to exchange transfusion in the management of hyperbilirubinaemia in term neonates?
30 Aug 2009 - Neuroimmune aspects of the pathogenesis of Tourette's syndrome and experience in the use of immunoglobulins in children.
30 Aug 2009 - Excellent renal allograft survival in donor-specific antibody transplant patients--role of intravenous immunoglobulin and rabbit antithymocyte globulin.
13 Aug 2009 - Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
13 Aug 2009 - Comèl-Netherton syndrome defined as primary immunodeficiency.
12 Aug 2009 - Low-affinity Fcgamma receptors, autoimmunity and infection.
11 Aug 2009 - A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs.
3 Aug 2009
See a longer list of these articles.
Technical information about 'Immunoglobulins, Intravenous'
Definition: Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
Registry Number: 0
Descriptor UI: D016756
Alternative terms: Immunoglobulins, Intravenous; Immune Globulin, Intravenous; Intravenous Immune Globulin; IVIG; Intravenous IG; Intravenous Immunoglobulins; IV Immunoglobulins; Immunoglobulins, IV; Antibodies, Intravenous; Intravenous Antibodies; Venoglobulin-I; Venoglobulin I; VenoglobulinI; Gamimune; Gamimmune; Gamimune N; Gamimmune N; Gammagard; Gammonativ; Globulin-N; Globulin N; GlobulinN; Intraglobin; Intraglobin F; Iveegam; Modified Immune Globulin (Anti-Echovirus Antibody); Sandoglobulin; Venimmune; Venoglobulin; Alphaglobin; Endobulin;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; biosynthesis; blood; cerebrospinal fluid; classification; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacology; physiology; poisoning; radiation effects; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; pharmacokinetics; standards;
Pharmacological Action: Immunologic Factors;
Tree Number: D12.776.124.486.485.114.619.393.536; D12.776.124.486.485.114.632; D12.776.124.790.651.114.632; D12.776.377.715.548.114.632;
Online Note: use IMMUNOGLOBULINS, INTRAVENOUS (NM) to search GLOBULIN-N (NM) 1986-91, VENOGLOBULIN (NM) 1983-91, GAMMONATIV (NM) & INTRAGLOBIN (NM) 1982-91, and SANDOGLOBULIN (NM) & MODIFIED IMMUNE GLOBULIN (ANTI-ECHOVIRUS ANTIBODY) (NM) 1981-91.
History Note: 92; GLOBULIN-N was NM 1986-91; VENOGLOBULIN was NM 1983-91; GAMMONATIV & INTRAGLOBIN were NM 1982-91; SANDOGLOBULIN & MODIFIED IMMUNE GLOBULIN (ANTI-ECHOVIRUS ANTIBODY) were NM 1981-91